Skip to main content
Premium Trial:

Request an Annual Quote

Meridian Bioscience Receives $5.5M From NIH to Expand SARS-CoV-2 Test Production

NEW YORK – Meridian Bioscience said on Wednesday that it has received $5.5 million from the National Institute of Health's Rapid Acceleration of Diagnostics initiative, along with a grant of undisclosed size from JobsOhio, to expand production capacity of its SARS-CoV-2 PCR test.

The funding will be used to increase production of the firm's Revogene test kits in its Quebec City, Canada facility, as well as to build a new semi-automated two-line production facility in Newtown, Ohio. The expansion will be completed in phases and is expected to result in a production capacity of 800,000 tests per month by the end of 2021, the company said in a statement.

The RADx grant is the second Meridian has received, after a $1 million grant in December to expedite the launch of its Revogene SARS-CoV-2 test. The new grant signals a move to Phase 2 of the RADx initiative, which is focused on scaling manufacturing to increase testing capacity in the US. The company submitted the Revogene test to the US Food and Drug Administration for Emergency Use Authorization in December. 

Meridian also received a JobsOhio Economic Development Grant as part of its commitment to create 45 new jobs in Newtown and invest more than $7 million in Ohio, the company said. Newton also provided tax abatements for the buildout of the newly-leased facility. Meridian declined to disclose the amount of the JobsOhio grant.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.